Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Replacement: AGM Statement

18 Apr 2008 11:56

W.H. Ireland Group PLC18 April 2008 The following announcement replaces that released under RNS number 6529S and includes additional details relating to the outcome of the AGM: WH Ireland Group plc AGM Statement At the Annual General Meeting of W H Ireland Group plc ("WH Ireland" or "theGroup"), Sir David Trippier, Chairman, made the following statement: "It is pleasing to be able to report to shareholders on another successful yearfor the Group. Last year, we continued to invest in our business, adding two newfund management teams and our IFA business in Bristol and increasing ourinvestment in our Australian business. We will continue to expand our threeprimary business activities in parallel with the objective of achieving abalanced, diversified business, built on the foundation of strong asset base. "Shareholders will have seen our recent announcement detailing a significantinvestment in our Group by a consortium of individuals who are committed toassisting us to take our strategy forward. I am sure that the Group will deriveconsiderable benefit from their expertise within the financial services sectorand I would like to take this opportunity to welcome them as new shareholders. "In February, in the Chief Executive's report to shareholders, it was statedthat "Market conditions deteriorated during the second half of our year and weare yet to see signs of a significant or sustained recovery. Current economicforecasts suggest that the year will prove testing in many respects but ourcorporate finance operation continues to be active." This remains the case. "Nonetheless, the Board remains confident in its strategy of continueddevelopment of the Group's position within our chosen markets and will continueto pursue opportunities for growth, both organic and through acquisitions, onshareholders' behalf. "I have been Chairman of W H Ireland for some 15 years during which time I haveseen enormous changes within the industry and growth within the Group. Turnoverhas increased some 40 fold which is a considerable achievement and a positivereflection on the commitment of all concerned from directors down. "In conjunction with the Consortium transaction announced earlier this month, Ialong with John Lawrence will be retiring from the Board in the near term. Iwould like to take this opportunity to thank my board friends and colleagueswithin the company and I wish them the very best for the future. "I can also confirm that at today's AGM all resolutions, except resolution 7,were duly passed. The effect of resolution 7 not having been passed is that,going forward, the Directors do not have the ability to allot shares for cashwithout first going through the statutory pre-emption procedure or without firstobtaining the appropriate power and authority from the Company's shareholders. However, it should be noted that the result of the AGM in no way affects thetransaction entered into on 31 March 2008 with the Consortium. If and to theextent that shares are allotted pursuant to that transaction, such allotmentwill be covered by the power granted to the Directors at last year's AGM. Itshould also be noted that the allotment of shares pursuant to the exercise ofshare options granted by the Company is unaffected by resolution 7 not havingbeen passed" For further information, please contact:- Laurie Beevers WH Ireland Group plc 0161 832 6644Greg Cant Rothschild 0161 827 3800Zoe Biddick Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Aug 20232:59 pmRNSResult of General Meeting and Total Voting Rights
31st Jul 20237:25 amRNSPosting of Circular and Notice of General Meeting
28th Jul 20238:53 amRNSResult of Placing
28th Jul 20237:00 amRNSTrading Update & Proposed Placing
22nd Jun 20239:05 amRNSESOT Purchases
15th Jun 20234:57 pmRNSESOT Purchases
24th Apr 20232:11 pmRNSESOT Purchases
21st Apr 20239:20 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSYear End Trading Update
14th Mar 202311:39 amRNSESOT Purchases
9th Feb 20239:10 amRNSESOT Trading
25th Jan 20238:47 amRNSTotal Voting Rights
17th Jan 20238:44 amRNSESOT Purchases
11th Jan 202310:45 amRNSIssue of Equity - Total Voting Rights
20th Dec 20222:08 pmRNSTR-1: Notification of major holdings
16th Dec 202210:19 amRNSRecent appointments across the Group
16th Dec 20227:00 amRNSInterim Results
7th Dec 20227:00 amRNSESOT Purchases
7th Nov 20225:00 pmRNSESOT Trading
4th Nov 20223:45 pmRNSESOT Trading
4th Oct 20228:18 amRNSESOT Purchases
8th Sep 20224:10 pmRNSResult of AGM
8th Sep 20228:23 amRNSESOT Purchases
5th Aug 20227:00 amRNSESOT Purchases
1st Aug 202210:18 amRNSPDMR Shareholding
27th Jul 20227:00 amRNSFinal Results and Notice of AGM
19th Jul 20227:00 amRNSConfirmation of Chairman Appointment
12th Jul 20227:00 amRNSESOT Purchases
20th Jun 20227:00 amRNSESOT Purchases
10th May 20227:00 amRNSNew Debt Capital Markets Business
6th May 20227:37 amRNSESOT Purchases
27th Apr 20224:05 pmRNSIssue of Options
12th Apr 20228:51 amRNSESOT Purchases
31st Mar 20227:00 amRNSBoard Changes
9th Mar 20227:00 amRNSESOT Purchases
17th Feb 202211:23 amRNSPDMR Shareholdings
15th Feb 20227:00 amRNSDirectorate Update
11th Feb 20224:47 pmRNSTR-1: Notification of Major Holdings
11th Feb 20227:00 amRNSTR-1: Notification of Major Holdings
10th Feb 20229:11 amRNSESOT Purchases
7th Feb 202212:39 pmRNSIssue of Equity - Total Voting Rights
24th Jan 20225:12 pmRNSPDMR Shareholdings
18th Jan 20227:00 amRNSPDMR Shareholding
13th Jan 20227:00 amRNSDirectorate Change
6th Jan 20227:00 amRNSESOT Purchases
20th Dec 20217:00 amRNSAppointment of Head of Private Growth Capital
17th Dec 202111:32 amRNSPrivate Capital Team Update
15th Dec 20217:00 amRNSESOT Purchases
7th Dec 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.